Home/Investors/European Investment Bank (EIB) European Investment Bank (EIB)
Biotech Investor · 7 portfolio companies
Portfolio Companies
| Company | Stage | Valuation | Focus |
|---|
| Advicenne | Approved | $12.9M | Nephrology, Neurology |
| Inotrem | Phase 2 | — | Septic Shock, Inflammatory Diseases |
| Byondis | Phase 3 | — | Oncology |
| MedinCell | Commercial | — | Psychiatry, Schizophrenia |
| TreeFrog Therapeutics | Pre-clinical | — | Parkinson's Disease, Liver Disease |
| TRiCares | Phase 3 | — | Cardiovascular, Structural Heart Disease |
| Xeltis | Phase 3 | — | Cardiovascular, Regenerative Medicine |